Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Binding of Primaquine, Pentaquine, Pamaquine, and Plasmocid to Deoxyribonucleic Acid

LEONA P. WHICHARD, CARL R. MORRIS, JUDY M. SMITH and DAVID J. HOLBROOK JR.
Molecular Pharmacology November 1968, 4 (6) 630-639;
LEONA P. WHICHARD
Center for Research in Pharmacology and Toxicology School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARL R. MORRIS
Center for Research in Pharmacology and Toxicology School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUDY M. SMITH
Center for Research in Pharmacology and Toxicology School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID J. HOLBROOK JR.
Center for Research in Pharmacology and Toxicology School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The binding of four 8-aminoquinoline antimalarials (primaquine, pentaquine, pamaquine, and plasmocid) to native and denatured calf thymus DNA has been studied by equilibrium dialysis and direct spectrophotometry. The binding of the 8-aminoquinolines to DNA is (a) accompanied by a decrease in absorbance of the ligand, (b) decreased by an increase in ionic strength, (c) decreased by addition of Mg2+ to a greater extent than would be expected from ionic strength effects alone, and (d) decreased under some conditions by the presence of 4 M urea. In 0.01 M potassium phosphate (pH 6), the total binding of the 8-aminoquinolines to various DNA preparations at DNA nucleotide to aminoquinoline ratios of 6 or greater occurs in the following order: native DNA = denatured DNA > native DNA in 4 M urea > denatured DNA in 4 M urea. At low ionic strengths and pH 6, the binding of the singly protonated 8-aminoquinolines is less than, but comparable to, the binding of chloroquine, a divalent cation at the same pH. At a DNA nucleotide to aminoquinoline ratio of 10 and an ionic strength of 0.012 (pH 6), the percentages of the aminoquinolines bound to native DNA decrease in the following order: chloroquine > pentaquine > plasmocid > primaquine > pamaquine. At an ionic strength of 0.15 or greater, the binding of pentaquine and plasmocid equals or exceeds the binding of chloroquine to native DNA. Evidence is presented for the occurrence of at least two spectrally distinct bound forms for each 8-aminoquinoline.

ACKNOWLEDGMENTS The authors wish to express their appreciation to Dr. J. Logan Irvin, University of North Carolina, for the initial discussions which pointed out the potential for this project. We gratefully acknowledge the encouragement and support of this program by Dr. Thomas C. Butler.

  • Copyright ©, 1968, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 4, Issue 6
1 Nov 1968
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Binding of Primaquine, Pentaquine, Pamaquine, and Plasmocid to Deoxyribonucleic Acid
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Binding of Primaquine, Pentaquine, Pamaquine, and Plasmocid to Deoxyribonucleic Acid

LEONA P. WHICHARD, CARL R. MORRIS, JUDY M. SMITH and DAVID J. HOLBROOK
Molecular Pharmacology November 1, 1968, 4 (6) 630-639;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Binding of Primaquine, Pentaquine, Pamaquine, and Plasmocid to Deoxyribonucleic Acid

LEONA P. WHICHARD, CARL R. MORRIS, JUDY M. SMITH and DAVID J. HOLBROOK
Molecular Pharmacology November 1, 1968, 4 (6) 630-639;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Relapsed-Leukemia Model with NT5C2/PRPS1 Hotspot Mutations
  • The Binding Site for KCI807 in the Androgen Receptor
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics